Literature DB >> 22196936

The effect of ABCG1 deficiency on atherosclerotic lesion development in LDL receptor knockout mice depends on the stage of atherogenesis.

Illiana Meurs1, Bart Lammers, Ying Zhao, Ruud Out, Reeni B Hildebrand, Menno Hoekstra, Theo J C Van Berkel, Miranda Van Eck.   

Abstract

OBJECTIVE: As ABCG1 plays a role in cholesterol efflux, macrophage ABCG1 expression has been suggested to protect against atherosclerosis. However, we and others observed varying effects of ABCG1 deficiency on atherosclerotic lesion size. The objective of this study was to define the effect of ABCG1 deficiency during atherosclerotic lesion progression in LDL receptor knockout (LDLr(-/-)) mice. METHODS AND
RESULTS: ABCG1(-/-)/LDLr(-/-) and ABCG1(+/+)/LDLr(-/-) littermates were fed a Western-type diet for 10 and 12 weeks in order to study the effect of ABCG1 deficiency in the exponential phase of atherosclerotic lesion formation. At 10 weeks of diet feeding, a significant 1.5-fold increase in early atherosclerotic lesion size (130±12×10(3) μm(2)) was observed in ABCG1(-/-)/LDLr(-/-) mice compared to ABCG1(+/+)/LDLr(-/-) mice (88±11×10(3) μm(2); p<0.05). Interestingly, in more advanced lesions, induced by 12 weeks of WTD feeding, ABCG1(-/-)/LDLr(-/-) mice showed a significant 1.7-fold decrease in atherosclerotic lesion size (160±20×10(3) μm(2) vs 273±19×10(3) μm(2) in control mice; p<0.01), indicating that in the ABCG1(-/-)/LDLr(-/-) mice progression of lesion formation is retarded as compared to ABCG1(+/+)/LDLr(-/-) mice. In addition, correlation analysis performed on 7 independent published studies and the current study confirmed that ABCG1 is atheroprotective in early lesions, while the development of advanced lesions is stimulated.
CONCLUSIONS: It appears that the effect of ABCG1 deficiency on lesion development in LDLr(-/-) mice depends on the stage of atherogenesis, whereby the absence of ABCG1 leads to increased lesions at sizes<167×10(3) μm(2) while in more advanced stages of atherosclerosis enhanced apoptosis and/or compensatory mechanisms lead to retarded lesion progression. Copyright Â
© 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22196936     DOI: 10.1016/j.atherosclerosis.2011.11.024

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  17 in total

Review 1.  Mechanisms of foam cell formation in atherosclerosis.

Authors:  Dimitry A Chistiakov; Alexandra A Melnichenko; Veronika A Myasoedova; Andrey V Grechko; Alexander N Orekhov
Journal:  J Mol Med (Berl)       Date:  2017-08-07       Impact factor: 4.599

2.  The transcription levels of ABCA1, ABCG1 and SR-BI are negatively associated with plasma CRP in Chinese populations with various risk factors for atherosclerosis.

Authors:  Chengjiang Li; Renyong Guo; Juanya Lou; Huali Zhou
Journal:  Inflammation       Date:  2012-10       Impact factor: 4.092

3.  ABCA1, ABCG1, and Cholesterol Homeostasis.

Authors:  Xiao-Hua Yu; Chao-Ke Tang
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

4.  Inhibition of mTOR protects the blood-brain barrier in models of Alzheimer's disease and vascular cognitive impairment.

Authors:  Candice E Van Skike; Jordan B Jahrling; Angela B Olson; Naomi L Sayre; Stacy A Hussong; Zoltan Ungvari; James D Lechleiter; Veronica Galvan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-12-22       Impact factor: 4.733

5.  Complement factor C5a induces atherosclerotic plaque disruptions.

Authors:  Anouk Wezel; Margreet R de Vries; H Maxime Lagraauw; Amanda C Foks; Johan Kuiper; Paul H A Quax; Ilze Bot
Journal:  J Cell Mol Med       Date:  2014-08-15       Impact factor: 5.310

6.  ABCG1-mediated generation of extracellular cholesterol microdomains.

Authors:  Sebastian R Freeman; Xueting Jin; Joshua J Anzinger; Qing Xu; Sonya Purushothaman; Michael B Fessler; Lia Addadi; Howard S Kruth
Journal:  J Lipid Res       Date:  2013-11-08       Impact factor: 5.922

7.  Cholesterol efflux in megakaryocyte progenitors suppresses platelet production and thrombocytosis.

Authors:  Andrew J Murphy; Nora Bijl; Laurent Yvan-Charvet; Carrie B Welch; Neha Bhagwat; Adili Reheman; Yiming Wang; James A Shaw; Ross L Levine; Heyu Ni; Alan R Tall; Nan Wang
Journal:  Nat Med       Date:  2013-04-14       Impact factor: 53.440

8.  C-reactive protein/oxidised low-density lipoprotein/β2-glycoprotein I complex promotes atherosclerosis in diabetic BALB/c mice via p38mitogen-activated protein kinase signal pathway.

Authors:  Rui Zhang; Sai-Jun Zhou; Chun-Jun Li; Xiao-Nan Wang; Yun-Zhao Tang; Rui Chen; Lin Lv; Qian Zhao; Qiu-Ling Xing; De-Min Yu; Pei Yu
Journal:  Lipids Health Dis       Date:  2013-03-26       Impact factor: 3.876

9.  Characterization of the role of a highly conserved sequence in ATP binding cassette transporter G (ABCG) family in ABCG1 stability, oligomerization, and trafficking.

Authors:  Faqi Wang; Ge Li; Hong-mei Gu; Da-wei Zhang
Journal:  Biochemistry       Date:  2013-12-18       Impact factor: 3.162

10.  Promotion of atherosclerosis by Helicobacter cinaedi infection that involves macrophage-driven proinflammatory responses.

Authors:  Shahzada Khan; H N Ashiqur Rahman; Tatsuya Okamoto; Tetsuro Matsunaga; Yukio Fujiwara; Tomohiro Sawa; Jun Yoshitake; Katsuhiko Ono; Khandaker Ahtesham Ahmed; Md Mizanur Rahaman; Kohta Oyama; Motohiro Takeya; Tomoaki Ida; Yoshiaki Kawamura; Shigemoto Fujii; Takaaki Akaike
Journal:  Sci Rep       Date:  2014-04-15       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.